FREMONT, Calif.--(BUSINESS WIRE)--DiscoveRx Corporation, a leading provider of Kinase assay technology, today announced the development for a rapid, quantitative fluorescence detection assay for PI3 Kinase suitable for HTS applications. PI 3-kinases have been linked to an extraordinarily diverse group of cellular functions, including cell growth, proliferation, differentiation, motility, survival and intracellular trafficking. Commonly used methods for kinase screening either rely on antibody detection of a phospho-epitope, or monitoring ATP depletion as the result of kinase activity in vitro. These assays tend to be less sensitive, less versatile and more complicated to miniaturize.
